Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 09, 2018

SELL
$45.7 - $58.03 $471,441 - $598,637
-10,316 Closed
0 $0
Q2 2018

Aug 13, 2018

SELL
$42.45 - $51.3 $31,413 - $37,962
-740 Reduced 6.69%
10,316 $1.5 Million
Q1 2018

Apr 20, 2018

SELL
$37.19 - $47.45 $11,119 - $14,187
-299 Reduced 2.63%
11,056 $1.54 Million
Q4 2017

Feb 14, 2018

BUY
$33.79 - $39.39 $1,723 - $2,008
51 Added 0.45%
11,355 $1.28 Million
Q3 2017

Oct 13, 2017

BUY
$36.29 - $38.83 $410,222 - $438,934
11,304
11,304 $1.24 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track B & T Capital Management Dba Alpha Capital Management Portfolio

Follow B & T Capital Management Dba Alpha Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B & T Capital Management Dba Alpha Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on B & T Capital Management Dba Alpha Capital Management with notifications on news.